Proceedings of the American Thoracic Society Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

The Proceedings of the American Thoracic Society 5:381-384 (2008)
© 2008 The American Thoracic Society
doi: 10.1513/pats.200709-154ET
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Weinmann, G. G.
Right arrow Articles by Sheingold, S.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weinmann, G. G.
Right arrow Articles by Sheingold, S.

The National Emphysema Treatment Trial (NETT)

A Study in Agency Collaboration

Gail G. Weinmann1, Yen-Pin Chiang2 and Steven Sheingold3

1 National Heart, Lung, and Blood Institute, Bethesda, Maryland; 2 Agency for Healthcare Research and Quality, Rockville, MD; and 3 Office of the Assistant Secretary for Planning and Evaluation, Department of Health and Human Services, Washington, DC

Correspondence and requests for reprints should be addressed to Gail G. Weinmann, M.D., Division of Lung Diseases, National Heart, Lung, and Blood Institute, Bethesda, MD 20892-7952. E-mail: gweinmann{at}nih.gov

ABSTRACT

The National Emphysema Treatment Trial (NETT) was a multicenter, randomized, controlled clinical trial, comparing the efficacy of lung volume reduction surgery (LVRS) plus medical management with rehabilitation to medical management with rehabilitation in 1,218 patients with severe emphysema. The NETT was a precedent-setting collaborative effort of three government agencies: the Centers for Medicare and Medicaid Services (CMS); the National Heart, Lung, and Blood Institute of the National Institutes of Health (NIH); and the Agency for Healthcare Research and Quality (AHRQ). NETT provided Medicare beneficiaries with controlled access to a promising but unproven procedure, while scientifically valid data on the efficacy and costs were collected to guide future use, coverage decisions, and policy. NETT demonstrates that collaboration among federal agencies and among health plans, researchers, and providers can successfully fulfill their differing missions simultaneously and is a productive approach to evaluating new treatments of mutual interest.

Key Words: lung volume reduction surgery • CMS • AHRQ • NHLBI






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Thoracic Society.